Horizon Pharma to Present at the 11th Annual JMP Securities Research Conference
(firmenpresse) - DEERFIELD, IL -- (Marketwire) -- 05/02/12 -- Horizon Pharma, Inc. (NASDAQ: HZNP) today announced that Timothy P. Walbert, chairman, president and chief executive officer, will present at the JMP Securities Research Conference on Monday, May 14, 2012 at 10:00 a.m. Pacific Time (1:00 p.m. Eastern time) in San Francisco, CA. Mr. Walbert will provide an overview of the Company and its corporate activities.
The presentation will be webcast live and may be accessed by visiting Horizon's website at . A replay of the webcast will be available for 10 business days.
Horizon Pharma, Inc. is a biopharmaceutical company that is developing and commercializing innovative medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. For more information, please visit .
Robert J. De Vaere
Executive Vice President and Chief Financial Officer
Investors
Kathy Galante
Burns McClellan, Inc.
212-213-0006
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 02.05.2012 - 05:30 Uhr
Sprache: Deutsch
News-ID 1109529
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
DEERFIELD, IL
Phone:
Kategorie:
Biotech
Anmerkungen:
Diese Pressemitteilung wurde bisher 74 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Horizon Pharma to Present at the 11th Annual JMP Securities Research Conference
"
steht unter der journalistisch-redaktionellen Verantwortung von
Horizon Pharma (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
